In March 2025, the company introduced new programs for the immediate-to-consumer giving of its Wegovy weight loss drug. The company set up a new pharmacy, identified as NovoCare, which would cost customers $499 a month for access to the drug, below 50 percent the expense of the drug through other pharmaceutical distribution networks.[53]Comprehensi